HOLX Hologic

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Developer and supplier of diagnostics, medical imaging, and surgical products focused on women’s health across four segments: Diagnostics, Breast Health, GYN Surgical, Skeletal Health
• • New digital cytology platform Genius Digital Diagnostics System cleared by FDA in Jan 2024, combines AI with volumetric imaging for cervical cancer detection

Management Discussion & Analysis

• • Cash and cash equivalents $1,959.5M, down $200.7M YoY due to stock repurchases, Gynesonics acquisition ($321.5M), capex $137M, strategic investments $35M
• • Operating cash flow $1,057.1M driven by net income $565.7M and $299.8M depreciation, offset by $141.6M deferred tax decrease

Risk Factors

• • Legal risk from ongoing governmental and regulatory investigations affecting potential litigation costs
• • Macroeconomic exposure to increased Weighted Average Cost of Capital (WACC) impacting goodwill fair value, goodwill $3.6B at risk if markets deteriorate

Management Discussion & Analysis

• • Revenue $1.05B total ($831.4M product + $216.4M service), product revenues up 1.7% YoY from $817.9M, driven by GYN Surgical (+8.0%) and Skeletal Health (+124.3%), partially offset by declines in Diagnostics (-0.8%) and Breast Health (-2.2%)
• • Operating margin by segment: Diagnostics 33.9% vs 33.0% YoY (+0.9pp); Breast Health 27.3% vs 24.3% YoY (+3.0pp); GYN Surgical 22.4% vs 35.2% YoY (-12.8pp); Skeletal Health 10.5% vs -19.6% YoY (+30.1pp)

Risk Factors

• • Ongoing COVID-19 pandemic impact on supply chain and demand remains a key carried-forward risk
• • Dependency on third-party suppliers could disrupt manufacturing and affect revenue continuity

What are the latest HOLX SEC filings in 2026?

Hologic (HOLX) has filed a 10-K annual report on November 18, 2025, a 10-Q quarterly report on January 29, 2026, an 8-K current report on April 7, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did HOLX file its most recent 10-K annual report?

Hologic (HOLX) filed its most recent 10-K annual report on November 18, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view HOLX 10-Q quarterly reports?

Hologic (HOLX)'s most recent 10-Q quarterly report was filed on January 29, 2026. SignalX displays every HOLX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has HOLX filed recently?

Hologic (HOLX)'s most recent 8-K was filed on April 7, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find HOLX insider trading activity (Form 4)?

SignalX aggregates every HOLX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does HOLX file with the SEC?

Hologic (HOLX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new HOLX filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Hologic (HOLX).

What is HOLX's SEC CIK number?

Hologic (HOLX)'s SEC CIK (Central Index Key) number is 859737. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 859737 to look up all HOLX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find HOLX return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Hologic (HOLX) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.